“The adoption of the Exclusive Sale Rights will only benefit pharmaceutical companies”
The pharmaceutical industry has paid attention on enforcement of the Patent Linkage System and the ‘Exclusive Sale Rights’ of the system.
The Korea Pharmaceutical Manufacturers Association (KPMA) held a press conferenceto explain an importance of the adoption of the ‘Exclusive Sale Rights’ and r...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
